Please provide your email address to receive an email when new articles are posted on . Adults with acromegaly are more likely to have hypertension, diabetes and other comorbidities than healthy ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A higher percentage of adults with acromegaly were ...

New York, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Acromegaly and Gigantism - Epidemiology Forecast to 2029" - https ...

A personalized treatment protocol was more effective for management of acromegaly -- also known as gigantism -- than the usual trial-and-error approach, the ...

Acromegaly is one of those diseases that immediately caught our attention when we first heard about it in medical school. We stared at the textbook pictures of big hands and coarse faces—maybe a very ...

The diagnosis of Acromegaly is confirmed by Growth Hormone Suppression Test. Other tests like Insulin-like Growth Factor-1 levels, X-rays, MRI and CT scan can also be used to detect acromegaly. The ...

When Ray Kohn started feeling pain in his knees and elbows in 2015, he attributed it to his work as a stunt driver and mechanic. But as the years went on, he began to notice his body changing in ...

SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the U.S. Food and Drug Administration (FDA) approved PALSONIFY TM (paltusotine) for ...

Something strange started happening to me about 10 years ago. My shoe size grew from 9 to 11+, my income dried up and the girlfriend I was going to marry left after we stopped having sex. It wasn't ...

The US Food and Drug Administration has approved the injectable long-acting somatostatin analog pasireotide (Signifor Long-Acting Release [LAR], Novartis) for the treatment of acromegaly in patients ...

Application supported by comprehensive clinical program, including two positive Phase 3 trials evaluating once-daily oral paltusotine in acromegalySAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- ...

The Endocrine Society has issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of acromegaly, a rare condition caused by excess growth hormone in the blood. The Endocrine Society ...